Peter Greenleaf - Chief Executive Officer, Director at Aurinia Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
AUPH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Peter Greenleaf - trading volume in the past year for Aurinia Pharmaceuticals Inc.

Holdings reported by Peter Greenleaf for Aurinia Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.79M $14.2M $7.92 Mar 4, 2025 Direct
Employee Stock Option (right to buy) 444K Feb 28, 2025 Direct Common Stock

Transactions reported by Peter Greenleaf for Aurinia Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.